|
COPYRIGHT 2005 International Medical News Group
SAN ANTONIO -- A small group of patients with severe systemic sclerosis have shown a durable response to autologous hematopoietic stem cell transplantation, with 8 of 13 transplanted patients remaining alive after a mean follow-up of 44 months, Zora Marjanovic, M.D., reported at the annual meeting of the American College of Rheumatology.
Stem cell transplantation has in recent years been investigated for use in diseases such as scleroderma following observations that some patients with autoimmune disease who...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
